Clinical trial · Observational
Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity
NCT05442177CI-TRIAL-00059437completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
We conducted an observational study to investigate the effectiveness and safety of Integrated Chinese Medicine With Western Medicine for bone marrow suppression induced by chemotherapy in patients with cancer. The TCM constitution and pulse diagnosis was also observed in the study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Myelosuppression | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chemotherapy and Integrated Chinese Medicine With Western Medicine for cancer treatment | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Chemotherapy-induced Hematologic Toxicity
- timeFrame
- one month
- description
- the blood cell count before and after chemotherapy was collected for measurement of severity of myelosuppression
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with cancer diagnosed through pathological histology * Patients with cancer under chemotherapy and Integrated Chinese Medicine With Western Medicine * Patients with an Eastern Cooperative Oncology Group Performance score of 0-2 * Patients having normal liver and kidney functions and electrocardiography and eligible for chemotherapy with normal bone marrow hematopoietic function * Patients who were voluntarily involved in this study Exclusion Criteria: * Cases that did not meet the inclusion criteria * Patients who could not cooperate with pulse diagnosis * Patients with underlying diseases such as chronic obstructive pulmonary disease, cardiac failure, chronic renal failure, cirrhosis, etc. * Patients with severe infection * Patients with severe cachexia
References
Publications (0)
Data not yet available
No reference posted for this study.